| pubmed-article:20046383 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0041491 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0686347 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:20046383 | lifeskim:mentions | umls-concept:C0332125 | lld:lifeskim |
| pubmed-article:20046383 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20046383 | pubmed:dateCreated | 2010-1-4 | lld:pubmed |
| pubmed-article:20046383 | pubmed:abstractText | Tyrosine hydroxylase (TH) is the rate-limiting enzyme in dopamine biosynthesis. Because the TH Val81Met polymorphism is located in the amino-terminal regulatory domain of the tetrameric enzyme, it is a candidate marker for susceptibility to dopamine-related traits. We investigated the hypothesis that TH Val81Met polymorphism can influence susceptibility to tardive dyskinesia (TD) in schizophrenia. | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20046383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20046383 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:20046383 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:20046383 | pubmed:issn | 1976-3026 | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:ParkYoung-Min... | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:OURY | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:KimSeung-Hyun... | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:LeeHeon-Jeong... | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:LimSe-WonSW | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:KangSeung-Gul... | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:ChoiJung-EunJ... | lld:pubmed |
| pubmed-article:20046383 | pubmed:author | pubmed-author:RheeMin KyuMK | lld:pubmed |
| pubmed-article:20046383 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20046383 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:20046383 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20046383 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20046383 | pubmed:pagination | 108-11 | lld:pubmed |
| pubmed-article:20046383 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20046383 | pubmed:articleTitle | No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia. | lld:pubmed |
| pubmed-article:20046383 | pubmed:affiliation | Department of Psychiatry, Korea University College of Medicine, Seoul, Korea. | lld:pubmed |
| pubmed-article:20046383 | pubmed:publicationType | Journal Article | lld:pubmed |
